Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F1AM1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,588
Award facts
- Contract value 100% obligated
- $47,588.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 22, 2026, valued at $47,588.05 for the supply of Otezla 30 mg tablets (60-count). This firm fixed-price delivery order, which concludes on January 23, 2026, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract is positioned to support military healthcare systems and veteran medical programs that rely on DLA's pharmaceutical supply chain. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains a substantial $999.999 billion IDC with DLA Troop Support Medical through December 2026.
This award exemplifies routine pharmaceutical procurement through an established contract vehicle that enables flexible ordering of diverse medications across multiple therapeutic domains. Otezla, an immunosuppressant used primarily for treating plaque psoriasis and psoriatic arthritis, is among the specialty medications covered under the company's broader pharmaceutical supply agreement with DLA. The delivery order structure and firm fixed pricing allow DLA to efficiently procure essential medications for military treatment facilities and Defense Health Agency beneficiaries without requiring new competitive solicitations, streamlining the acquisition process for routine medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F1AM1?
SPE2DR26F1AM1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1AM1 worth?
The government has obligated $47,588 on SPE2DR26F1AM1.
Is contract SPE2DR26F1AM1 an order under another contract?
Yes. SPE2DR26F1AM1 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AM1 competed?
The extent of competition for SPE2DR26F1AM1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award